Updated (10:31 a.m.): Updated with Tuesday morning price information.
NEW YORK (TheStreet) -- Jefferies increased its price target on Allergan (AGN) to $139, increased its estimates and set a "hold" rating. The firm noted double digit growth with productive R&D and superior execution.
The stock was up nearly 16% to $164.60 at 10:31 a.m. on Tuesday.
Must Read: Warren Buffett's 10 Favorite Growth Stocks